Literature DB >> 16604395

Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan.

Yen-Ching Lin1, May-Yung Yen, Wen-Ming Hsu, Hui-Chen Lee, An-Guor Wang.   

Abstract

PURPOSE: To investigate the clinical characteristics of patients with idiopathic optic neuritis (ON) in Taiwan and to assess the conversion rate to multiple sclerosis (MS) in these patients.
METHODS: We studied the medical records of a total of 109 patients with a clinical diagnosis of idiopathic ON treated in the Taipei Veterans General Hospital during the period from January 1986 to May 2003. Clinical characteristics, management, and disease courses were retrospectively reviewed. Our main focus was on the development of multiple sclerosis after an ON attack. Univariate and multivariate analyses were used to evaluate the risk indicators for MS conversion.
RESULTS: The patients (58 women, 51 men) had a mean age of 41.2 years at onset. ON was retrobulbar in 46.8% of the patients. Management with or without pulse therapy did not affect the final visual outcome. Female sex, retrobulbar type ON, recurrent cases, elevated cerebrospinal fluid (CSF) IgG index, and central nervous system (CNS) imaging abnormalities were identified as risk indicators for the development of MS (P < 0.05). The 2-year cumulative probability of developing MS was 5.92%, and the 5-year cumulative probability was 14.28%. The conversion rate to MS did not differ among treatment groups.
CONCLUSIONS: Idiopathic ON patients in Taiwan have an older age at onset and a higher percentage of optic disc edema than reported in previous literature. The characteristic features of ON patients associated with a high risk of developing MS are female sex, retrobulbar type ON, CNS imaging abnormalities, elevated CSF IgG index, and recurrence. Idiopathic ON patients in Taiwan display a significantly lower conversion rate to MS.

Entities:  

Mesh:

Year:  2006        PMID: 16604395     DOI: 10.1007/s10384-005-0281-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.211


  27 in total

Review 1.  Randomized controlled trials to assess therapies for multiple sclerosis.

Authors:  Dean M Wingerchuk; John H Noseworthy
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

2.  Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis.

Authors:  J L Frederiksen; H B Larsson; J Olesen
Journal:  Acta Neurol Scand       Date:  1992-09       Impact factor: 3.209

3.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

Authors:  J I O'Riordan; A J Thompson; D P Kingsley; D G MacManus; B E Kendall; P Rudge; W I McDonald; D H Miller
Journal:  Brain       Date:  1998-03       Impact factor: 13.501

4.  Acute optic neuritis and multiple sclerosis.

Authors:  Y Isayama; T Takahashi; T Shimoyoma; A Yamadori
Journal:  Neurology       Date:  1982-01       Impact factor: 9.910

5.  Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1997-12

6.  Acute optic neuritis: a prospective study of risk factors for multiple sclerosis.

Authors:  M A Hely; P G McManis; T J Doran; J C Walsh; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

7.  The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; J D Trobe; D I Kaufman; M J Kupersmith; D W Paty; C H Brown
Journal:  N Engl J Med       Date:  1993-12-09       Impact factor: 91.245

8.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study.

Authors:  S P Morrissey; D H Miller; B E Kendall; D P Kingsley; M A Kelly; D A Francis; D G MacManus; W I McDonald
Journal:  Brain       Date:  1993-02       Impact factor: 13.501

9.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

10.  Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

Authors:  S M Leary; D H Miller; V L Stevenson; P A Brex; D T Chard; A J Thompson
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

View more
  17 in total

1.  Management of optic neuritis.

Authors:  Vimla Menon; Rohit Saxena; Ruby Misra; Swati Phuljhele
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

Review 2.  The optic nerve head in acquired optic neuropathies.

Authors:  Evelyn C O'Neill; Helen V Danesh-Meyer; Paul P Connell; Ian A Trounce; Michael A Coote; David A Mackey; Jonathan G Crowston
Journal:  Nat Rev Neurol       Date:  2010-03-09       Impact factor: 42.937

3.  Clinical characteristics of optic neuritis in Hong Kong population: 10-year review.

Authors:  Bonnie Nga Kwan Choy; Alex Lap Ki Ng; Jimmy Shiu Ming Lai
Journal:  Int Ophthalmol       Date:  2017-03-13       Impact factor: 2.031

4.  Early relapse in multiple sclerosis-associated optic neuritis following the use of interferon beta-1a in Chinese patients.

Authors:  An-Guor Wang; Yen-Ching Lin; Shuu-Jiun Wang; Ching-Piao Tsai; May-Yung Yen
Journal:  Jpn J Ophthalmol       Date:  2006-12-18       Impact factor: 2.447

Review 5.  A Comparison of Optic Neuritis in Asian and in Western Countries.

Authors:  Lin-Chung Woung; Hui-Chuan Chung; Jieh-Ren Jou; Kai-Chen Wang; Pai-Huei Peng
Journal:  Neuroophthalmology       Date:  2011-03-20

6.  Measurement of retinal nerve fiber layer thickness in optic atrophy eyes of patients with optic neuritis using optical coherence tomography.

Authors:  Xin-Ling Wang; Tao Yu; De-Zhao Xia; Jin-Song Zhang; Qi-chang Yan; Ya-Hong Luo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-27       Impact factor: 3.117

7.  Development of a Prognostic Model for Predicting Multiple Sclerosis After Optic Neuritis: A Secondary Analysis of Data From the Optic Neuritis Treatment Trial.

Authors:  Wenjing Luo; Xinlei Deng; Xiaoyu Xu; Ruitong Song; Meifeng Luo; Heather E Moss; Yi Du
Journal:  J Neuroophthalmol       Date:  2021-10-22       Impact factor: 4.415

8.  The effect of interferon beta-1a on optic neuritis relapse in patients with multiple sclerosis.

Authors:  Yan-Ming Chen; Chih-Chao Yang; I-Hua Wang; Fung-Rong Hu; Jieh-Ren Jou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-06       Impact factor: 3.117

9.  Analysis of the causes of optic disc swelling.

Authors:  Jong Jin Jung; Seung-Hee Baek; Ungsoo Samuel Kim
Journal:  Korean J Ophthalmol       Date:  2011-01-17

10.  Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis.

Authors:  Chuntao Lai; Qinglin Chang; Guohong Tian; Jiawei Wang; Hongxia Yin; Wu Liu
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.